"Factor X" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Storage-stable glycoprotein blood coagulation factor that can be activated to factor Xa by both the intrinsic and extrinsic pathways. A deficiency of factor X, sometimes called Stuart-Prower factor deficiency, may lead to a systemic coagulation disorder.
| Descriptor ID |
D005170
|
| MeSH Number(s) |
D12.776.124.125.400 D23.119.400
|
| Concept/Terms |
Factor X- Factor X
- Factor Ten
- Autoprothrombin III
- Coagulation Factor X
- Factor X, Coagulation
- Blood Coagulation Factor X
- Stuart Factor
- Stuart Prower Factor
- Stuart-Prower Factor
- Factor 10
|
Below are MeSH descriptors whose meaning is more general than "Factor X".
Below are MeSH descriptors whose meaning is more specific than "Factor X".
This graph shows the total number of publications written about "Factor X" by people in this website by year, and whether "Factor X" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Factor X" by people in Profiles.
-
Zimowski KL, McGuinn CE, Abajas YL, Schultz CL, Kaicker S, Batsuli G. Use of plasma-derived factor X concentrate in neonates and infants with congenital factor X deficiency. J Thromb Haemost. 2020 10; 18(10):2551-2556.
-
Sculpher MJ, Lozano-Ortega G, Sambrook J, Palmer S, Ormanidhi O, Bakhai A, Flather M, Steg PG, Mehta SR, Weintraub W. Fondaparinux versus Enoxaparin in non-ST-elevation acute coronary syndromes: short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial. Am Heart J. 2009 May; 157(5):845-52.
-
Peyvandi F, De Cristofaro R, Akhavan S, Carew JA, Landolfi R, Bauer KA, Mannucci PM. Two naturally occurring mutations on FVII gene (S363I-W364C) altering intrinsic catalytic activity. Thromb Haemost. 2002 Nov; 88(5):750-5.
-
Schick BP, Gradowski JF, San Antonio JD, Martinez J. Novel design of peptides to reverse the anticoagulant activities of heparin and other glycosaminoglycans. Thromb Haemost. 2001 Mar; 85(3):482-7.
-
Corseaux D, Meurice T, Six I, Rugeri L, Ezekowitz MD, Rouvier P, Bordet R, Bauters C, Jude B. Basic fibroblast growth factor increases tissue factor expression in circulating monocytes and in vascular wall. Circulation. 2000 Apr 25; 101(16):2000-6.